MGLL, monoglyceride lipase, 11343

N. diseases: 125; N. variants: 7
Disease: nervous system disorder ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027765
Disease: nervous system disorder
nervous system disorder 		0.030 Biomarker group BEFREE Preclinically, inhibition of MAGL is known to provide therapeutic benefits for a number of neurological disorders. 31483137 2019
CUI: C0027765
Disease: nervous system disorder
nervous system disorder 		0.030 Biomarker group BEFREE These findings support the clinical development of MGLL inhibitors as a differentiated mechanism to treat pain and other neurologic disorders. 30305428 2018
CUI: C0027765
Disease: nervous system disorder
nervous system disorder 		0.030 Biomarker group BEFREE Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. 30067909 2018